By How Much Can CVS’s Revenue & EBITDA Grow In The Next 5 Years: Trefis Estimate
Revenue CAGR: ~5% [Most of the growth is expected from Pharmacy Services Business]
EBITDA CAGR: ~5%
Have more questions about CVS Health (NYSE:CVS)? Click on the links below:
- What is CVS’s Current Revenue & EBITDA Breakdown?
- What’s CVS’s Fundamental Value Based on Expected 2016 Results?
- By What Percentage Did CVS’s Revenue & EBITDA Grow In The Last 5 Years?
Notes:
1) The purpose of these analyses is to help readers focus on a few important things. We hope such lean communication sparks thinking, and encourages readers to comment and ask questions on the comment section, or email content@trefis.com
2) Figures mentioned are approximate values to help our readers remember the key concepts more intuitively. For precise figures, please refer to our detailed analysis for CVS Health
See More at Trefis | View Interactive Institutional Research (Powered by Trefis) Get Trefis Technology